Comparison Revance Therapeutics (RVNC) with Competitors
Revance Therapeutics (RVNC) industry is Biotechnology.
Profit Margin
RVNC-63.65%
Industry-0.77%
Upside-62.88%
Operating Margin
RVNC-53.87%
Industry-2055.25%
Upside+2001.38%
Debt-to-Equity
RVNC1477.84%
Industry28.27%
Upside+5127.92%
Free Cash Flow Yield
RVNC-53.98%
Industry-1.75%
Upside-52.23%
P/E
RVNC-1.86
Industry-20.52
Upside+1865.80%
P/S
RVNC1.48
Industry10.01
Upside-85.22%
P/B
RVNC-2.33
Industry5.15
Upside-748.00%